[Candidacidal activity of human polymorphonuclear neutrophils and antibacterial chemotherapy].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001790:Blood Physiological Phenomena; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000097:blood; D002701:Chloramphenicol / Q000494:pharmacology; D003428:Cross Infection / Q000209:etiology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009504:Neutrophils / Q000187:drug effects*; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D010587:Phagocytosis / Q000187:drug effects*; D012382:Rolitetracycline / Q000494:pharmacology; D013416:Sulfamerazine / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002701:Chloramphenicol; D012382:Rolitetracycline; D010400:Penicillin G; D013416:Sulfamerazine
Pouvoir candidacide des polynucléaires neutrophiles humains et chimiothérapie antibactérienne